Biotech

All Articles

Acepodia, Pfizer click on together for chemistry-based tissue treatment

.Contact it a scenario of excellent chemical make up: Acepodia, a biotech based on Nobel Champion sc...

Praxis epilepsy drug reduces confiscations in period 2 trial

.Practice Accuracy Medicines has actually scored one more midphase succeed in epilepsy this year, wi...

Three officers surrender as Dyne posts combined information for DMD applicant

.After getting away from a professional grip many years back, Dyne Therapy has actually shown brand ...

Arrowhead fires off phase 3 information in unusual metabolic ailment in front of market clash with Ionis

.Arrowhead Pharmaceuticals has actually revealed its give in advance of a potential face-off along w...

Pfizer, Valneva reveal lyme illness go reliable for second booster

.Pfizer as well as Valneva may possess concerning two more years to stand by prior to they help make...

Fierce Biotech Managing Editor Ayla Ellison Talks Patronize Michelle Benz on the Future of Biotech.

.Permit's study a chat along with Ayla Ellison, Ferocious Biotech Editor-in-Chief and Michelle Benz ...

New records demonstrate how Bayer's asundexian fell short to stop strokes

.Bayer suspended the stage 3 test for its own variable XIa inhibitor asundexian late in 2014 after t...

Sanofi's tolebrutinib fails 2 of 3 late-stage MS trials

.Sanofi is actually still bented on taking its own a number of sclerosis (MS) med tolebrutinib to th...

Galapagos' stockpile as fund shows intent to shape its own evolution

.Galapagos is happening under added pressure from real estate investors. Having built a 9.9% risk in...

Cell- focused Sana scoops 1st CSO-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our summary of notable leadership hirings, shootings and ...